Cargando…

The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain

Neuropathic pain results from neuroplasticity in nociceptive neuronal networks. Here we demonstrate that control of alternative pre-mRNA splicing, through the splice factor serine-arginine splice factor 1 (SRSF1), is integral to the processing of nociceptive information in the spinal cord. Neuropath...

Descripción completa

Detalles Bibliográficos
Autores principales: Hulse, Richard P., Drake, Robert A.R., Bates, David O., Donaldson, Lucy F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113660/
https://www.ncbi.nlm.nih.gov/pubmed/27616424
http://dx.doi.org/10.1016/j.nbd.2016.09.009
_version_ 1782468226914975744
author Hulse, Richard P.
Drake, Robert A.R.
Bates, David O.
Donaldson, Lucy F.
author_facet Hulse, Richard P.
Drake, Robert A.R.
Bates, David O.
Donaldson, Lucy F.
author_sort Hulse, Richard P.
collection PubMed
description Neuropathic pain results from neuroplasticity in nociceptive neuronal networks. Here we demonstrate that control of alternative pre-mRNA splicing, through the splice factor serine-arginine splice factor 1 (SRSF1), is integral to the processing of nociceptive information in the spinal cord. Neuropathic pain develops following a partial saphenous nerve ligation injury, at which time SRSF1 is activated in damaged myelinated primary afferent neurons, with minimal found in small diameter (IB(4) positive) dorsal root ganglia neurons. Serine arginine protein kinase 1 (SRPK1) is the principal route of SRSF1 activation. Spinal SRPK1 inhibition attenuated SRSF1 activity, abolished neuropathic pain behaviors and suppressed central sensitization. SRSF1 was principally expressed in large diameter myelinated (NF200-rich) dorsal root ganglia sensory neurons and their excitatory central terminals (vGLUT1 + ve) within the dorsal horn of the lumbar spinal cord. Expression of pro-nociceptive VEGF-A(xxx)a within the spinal cord was increased after nerve injury, and this was prevented by SRPK1 inhibition. Additionally, expression of anti-nociceptive VEGF-A(xxx)b isoforms was elevated, and this was associated with reduced neuropathic pain behaviors. Inhibition of VEGF receptor-2 signaling in the spinal cord attenuated behavioral nociceptive responses to mechanical, heat and formalin stimuli, indicating that spinal VEGF receptor-2 activation has potent pro-nociceptive actions. Furthermore, intrathecal VEGF-A(165)a resulted in mechanical and heat hyperalgesia, whereas the sister inhibitory isoform VEGF-A(165)b resulted in anti-nociception. These results support a role for myelinated fiber pathways, and alternative pre-mRNA splicing of factors such as VEGF-A in the spinal processing of neuropathic pain. They also indicate that targeting pre-mRNA splicing at the spinal level could lead to a novel target for analgesic development.
format Online
Article
Text
id pubmed-5113660
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Academic Press
record_format MEDLINE/PubMed
spelling pubmed-51136602016-12-01 The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain Hulse, Richard P. Drake, Robert A.R. Bates, David O. Donaldson, Lucy F. Neurobiol Dis Article Neuropathic pain results from neuroplasticity in nociceptive neuronal networks. Here we demonstrate that control of alternative pre-mRNA splicing, through the splice factor serine-arginine splice factor 1 (SRSF1), is integral to the processing of nociceptive information in the spinal cord. Neuropathic pain develops following a partial saphenous nerve ligation injury, at which time SRSF1 is activated in damaged myelinated primary afferent neurons, with minimal found in small diameter (IB(4) positive) dorsal root ganglia neurons. Serine arginine protein kinase 1 (SRPK1) is the principal route of SRSF1 activation. Spinal SRPK1 inhibition attenuated SRSF1 activity, abolished neuropathic pain behaviors and suppressed central sensitization. SRSF1 was principally expressed in large diameter myelinated (NF200-rich) dorsal root ganglia sensory neurons and their excitatory central terminals (vGLUT1 + ve) within the dorsal horn of the lumbar spinal cord. Expression of pro-nociceptive VEGF-A(xxx)a within the spinal cord was increased after nerve injury, and this was prevented by SRPK1 inhibition. Additionally, expression of anti-nociceptive VEGF-A(xxx)b isoforms was elevated, and this was associated with reduced neuropathic pain behaviors. Inhibition of VEGF receptor-2 signaling in the spinal cord attenuated behavioral nociceptive responses to mechanical, heat and formalin stimuli, indicating that spinal VEGF receptor-2 activation has potent pro-nociceptive actions. Furthermore, intrathecal VEGF-A(165)a resulted in mechanical and heat hyperalgesia, whereas the sister inhibitory isoform VEGF-A(165)b resulted in anti-nociception. These results support a role for myelinated fiber pathways, and alternative pre-mRNA splicing of factors such as VEGF-A in the spinal processing of neuropathic pain. They also indicate that targeting pre-mRNA splicing at the spinal level could lead to a novel target for analgesic development. Academic Press 2016-12 /pmc/articles/PMC5113660/ /pubmed/27616424 http://dx.doi.org/10.1016/j.nbd.2016.09.009 Text en Crown Copyright © 2016 Published by Elsevier Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hulse, Richard P.
Drake, Robert A.R.
Bates, David O.
Donaldson, Lucy F.
The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain
title The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain
title_full The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain
title_fullStr The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain
title_full_unstemmed The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain
title_short The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain
title_sort control of alternative splicing by srsf1 in myelinated afferents contributes to the development of neuropathic pain
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113660/
https://www.ncbi.nlm.nih.gov/pubmed/27616424
http://dx.doi.org/10.1016/j.nbd.2016.09.009
work_keys_str_mv AT hulserichardp thecontrolofalternativesplicingbysrsf1inmyelinatedafferentscontributestothedevelopmentofneuropathicpain
AT drakerobertar thecontrolofalternativesplicingbysrsf1inmyelinatedafferentscontributestothedevelopmentofneuropathicpain
AT batesdavido thecontrolofalternativesplicingbysrsf1inmyelinatedafferentscontributestothedevelopmentofneuropathicpain
AT donaldsonlucyf thecontrolofalternativesplicingbysrsf1inmyelinatedafferentscontributestothedevelopmentofneuropathicpain
AT hulserichardp controlofalternativesplicingbysrsf1inmyelinatedafferentscontributestothedevelopmentofneuropathicpain
AT drakerobertar controlofalternativesplicingbysrsf1inmyelinatedafferentscontributestothedevelopmentofneuropathicpain
AT batesdavido controlofalternativesplicingbysrsf1inmyelinatedafferentscontributestothedevelopmentofneuropathicpain
AT donaldsonlucyf controlofalternativesplicingbysrsf1inmyelinatedafferentscontributestothedevelopmentofneuropathicpain